Summary: Aetna modified CPB 0069, its lymphedema coverage policy, effective April 29, 2026. Here's what billing teams need to know before submitting claims.

Aetna, a CVS Health company, updated Clinical Policy Bulletin 0069 governing lymphedema treatment and related services. The policy document does not list specific CPT or HCPCS codes in the data available at publication — but the underlying coverage criteria, medical necessity standards, and prior authorization requirements are what drive claim outcomes for lymphedema billing. Review your lymphedema billing workflows now and pull the full CPB 0069 text directly from Aetna's portal before April 29, 2026.


Quick-Reference Table

Field Detail
Payer Aetna, a CVS Health company
Policy Lymphedema — CPB 0069
Policy Code CPB 0069
Change Type Modified
Effective Date April 29, 2026
Impact Level High
Specialties Affected Physical therapy, occupational therapy, vascular surgery, oncology, lymphedema therapy, durable medical equipment suppliers
Key Action Pull the full CPB 0069 text from Aetna's portal and audit your lymphedema billing criteria against the updated policy before April 29, 2026

Aetna Lymphedema Coverage Criteria and Medical Necessity Requirements 2026

Aetna's lymphedema coverage policy under CPB 0069 in the CPB 0069 Aetna system has historically set specific medical necessity thresholds for both treatment services and related equipment. Lymphedema billing depends on satisfying those thresholds at the claim level — not just at the point of care.

The core medical necessity framework for lymphedema typically requires a physician diagnosis of lymphedema, documented functional impairment, and a treatment plan from a qualified provider. Aetna has historically required that conservative measures be attempted before certain interventions are approved. What changed in this April 29, 2026 update is what billing teams need to verify directly against the full policy text.

Prior authorization is a real risk factor here. Aetna requires prior auth for many lymphedema-related services and durable medical equipment, including compression devices. If your team submits claims without confirming prior authorization requirements under the updated CPB 0069, you face immediate claim denial exposure.

The Aetna lymphedema coverage policy under CPB 0069 has historically distinguished between:

#Covered Indication
1Complete decongestive therapy (CDT) — typically covered when medical necessity criteria are met
2Pneumatic compression devices — covered as durable medical equipment with specific qualifying criteria
3Surgical interventions (lymphovenous bypass, vascularized lymph node transfer) — historically considered experimental or subject to narrow coverage criteria
+ 1 more indications

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Because the full policy data was not available at publication, your billing team should not rely on assumptions about which of these categories changed. Pull the current CPB 0069 text and compare it line by line against the prior version.

If your practice sees significant lymphedema volume — especially post-mastectomy patients or patients with cancer-related lymphedema — this coverage policy update warrants a formal review with your compliance officer before the effective date.


Aetna Lymphedema Exclusions and Non-Covered Indications

Aetna's CPB 0069 has historically excluded or designated as experimental several lymphedema-related interventions. These deserve close attention because billing for excluded services is a direct path to claim denial and potential overpayment recovery.

Surgical procedures for lymphedema have been a consistent exclusion or experimental designation in prior versions of CPB 0069. Lymphovenous anastomosis, vascularized lymph node transfer, and liposuction for lymphedema have all carried non-covered or investigational status under earlier iterations of this policy. Whether this April 2026 modification changes those designations is precisely what your billing team needs to confirm.

Preventive lymphedema services — screening, prophylactic compression, or early intervention programs without a confirmed diagnosis — have also historically fallen outside Aetna's covered indications under this policy. Billing for prevention when the diagnosis code doesn't support active lymphedema is a common denial trigger.

Self-management supplies and maintenance-phase equipment beyond what the plan defines as medically necessary have also been subject to denial. Compression bandaging systems, garments, and home therapy devices each carry their own reimbursement criteria under Aetna's policy framework.


Coverage Indications at a Glance

Because the specific policy data was not available at publication time, the table below reflects CPB 0069's historical coverage framework. Verify each row against the updated April 29, 2026 policy text before using this as a billing reference.

Indication Status Relevant Codes Notes
Complete decongestive therapy (CDT) by qualified therapist Historically Covered Not listed in available data Medical necessity documentation required; verify prior auth
Pneumatic compression device for home use Historically Covered (DME) Not listed in available data Requires qualifying diagnosis and prior authorization; DME supplier rules apply
Manual lymphatic drainage (MLD) by therapist Historically Covered Not listed in available data Frequency limits often apply; document medical necessity per visit
+ 5 more indications

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

This policy is now in effect (since 2026-04-29). Verify your claims match the updated criteria above.

Aetna Lymphedema Billing Guidelines and Action Items 2026

Here's what your billing team needs to do before April 29, 2026.

#Action Item
1

Pull the full CPB 0069 text from Aetna's provider portal now. Don't rely on this post or any secondary summary. The effective date is April 29, 2026 — you have a narrow window to review the actual language, compare it to the prior version, and identify what changed.

2

Run a prior authorization audit on your open lymphedema cases. Aetna prior authorization requirements for lymphedema services and DME can shift with policy modifications. Any pneumatic compression device orders, ongoing CDT authorizations, or surgical consults pending under Aetna should be reviewed against the updated CPB 0069 criteria before you submit.

3

Verify diagnosis code specificity on every lymphedema claim. Aetna's medical necessity determinations are diagnosis-code-driven. Secondary lymphedema (post-cancer treatment) and primary lymphedema carry different clinical evidence requirements. Make sure your ICD-10-CM codes accurately reflect the documented condition — not a generic or unspecified code that triggers a medical necessity review.

+ 3 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Sample Version Diff Line-by-line changes
Previous VersionCurrent Version
Coverage is considered experimental and investigational for all indicationsCoverage is considered medically necessary when specific criteria are met
Prior authorization is not requiredPrior authorization is required for initial treatment
Documentation must include clinical historyDocumentation must include clinical history
+ 1 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

CPT, HCPCS, and ICD-10 Codes for Lymphedema Under CPB 0069

The policy data available at publication does not list specific CPT, HCPCS, or ICD-10 codes. The updated CPB 0069 policy document does not include a code table in the information provided to PayerPolicy at this time.

This is important for your billing team. Aetna's lymphedema coverage policy under CPB 0069 almost certainly references specific procedure codes and diagnosis codes in its full text — but publishing guessed or invented codes here would be worse than publishing none. Submitting claims based on incorrect code-to-policy mappings creates denial risk and, in audit situations, overpayment exposure.

Pull the full CPB 0069 policy directly from Aetna's provider portal at app.payerpolicy.org/p/aetna/0069. The complete policy document will include the applicable code sets, coverage criteria by code, and any prior authorization requirements tied to specific procedure codes.

What we can tell you: lymphedema billing typically involves a range of therapy procedure codes, DME HCPCS codes for compression devices, and ICD-10-CM codes in the lymphedema category. The specific codes Aetna uses to adjudicate CPB 0069 claims are in the policy document — go get them before April 29, 2026.


Get the Full Picture

Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.

🔍 Search by any code 🔔 Real-time alerts 📊 Line-by-line diffs ⏰ Deadline tracking
Get Full Access → $99/mo · 14-day money-back guarantee